NEURONOX VERSUS BOTOX FOR SPASTIC EQUINUS GAIT IN CHILDREN WITH CEREBRAL PALSY: A RANDOMIZED, DOUBLE-BLINDED, CONTROLLED MULTICENTRE CLINICAL TRIAL
Shranjeno v:
KIM, K., ET AL., NEURONOX VERSUS BOTOX FOR SPASTIC EQUINUS GAIT IN CHILDREN WITH CEREBRAL PALSY: A RANDOMIZED, DOUBLE-BLINDED, CONTROLLED MULTICENTRE CLINICAL TRIAL. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, Vol. 53, no. 3 (2011), p. 239-244.
Ref.
175413
Lokacija:
SIIS R.727 Archivo
Palabras clave:
Ceguera, Discapacidad, Efectos, Evaluación de servicios, Innovaciones, Parálisis cerebral, Tratamiento médico
Ceguera, Discapacidad, Efectos, Evaluación de servicios, Innovaciones, Parálisis cerebral, Tratamiento médico
Podobne knjige/članki: NEURONOX VERSUS BOTOX FOR SPASTIC EQUINUS GAIT IN CHILDREN WITH CEREBRAL PALSY: A RANDOMIZED, DOUBLE-BLINDED, CONTROLLED MULTICENTRE CLINICAL TRIAL
- DOUBLE-BLIND RANDOMIZED MULTICENTRE TRIAL OF ACAMPROSATE IN MAINTAINING ABSTINENCE FROM ALCOHOL
- MULTICENTRE DOUBLE-BLIND STUDY OF EFFECT OF INTRATHECALLY ADMINISTERED NATURAL HUMAN FIBROBLAST INTERFERON ON EXACERBATIONS OF MULTIPLE SCLEROSIS
- NALTREXONE VERSUS ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE: A MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
- EFFICACY OF FLUVOXAMINE IN PREVENTING RELAPSE IN ALCOHOL DEPENDENCE: A ONE-YEAR, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTRE STUDY WITH ANALYSIS BY TIPOLOGY
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL EVALUATION OF A NICOTINE SUBLINGUAL TABLET IN SMOKING CESSATION
- BUPRENORPHINE VERSUS METHADONE MAINTENANCE THERAPY: A RANDOMIZED DOUBLE-BLIND TRIAL WITH 405 OPIOID-DEPENDENT PATIENTS